O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.89B
AUM Growth
+$717M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
126
New
Increased
Reduced
Closed

Top Buys

1 +$41.7M
2 +$37.3M
3 +$33.5M
4
HELP
Cybin Inc
HELP
+$24.7M
5
BRKR icon
Bruker
BRKR
+$23.5M

Top Sells

1 +$125M
2 +$65.8M
3 +$51.6M
4
AXSM icon
Axsome Therapeutics
AXSM
+$38.9M
5
SIBN icon
SI-BONE Inc
SIBN
+$38M

Sector Composition

1 Healthcare 99.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALMS
76
Alumis Inc
ALMS
$3.7B
$10.8M 0.22%
1,102,730
-823,693
BIOA
77
BioAge Labs
BIOA
$930M
$10.5M 0.21%
790,901
FOLD icon
78
Amicus Therapeutics
FOLD
$4.51B
$10.4M 0.21%
729,900
-915,500
WHWK
79
Whitehawk Therapeutics
WHWK
$165M
$10.1M 0.21%
4,166,000
ACET icon
80
Adicet Bio
ACET
$69.6M
$8.66M 0.18%
1,027,944
+312,498
RPTX
81
DELISTED
Repare Therapeutics
RPTX
$8.64M 0.18%
3,322,488
CELC icon
82
Celcuity
CELC
$5.17B
$8.54M 0.17%
85,664
+1,644
JBIO
83
Jade Biosciences
JBIO
$731M
$8.2M 0.17%
531,163
KNSA icon
84
Kiniksa Pharmaceuticals
KNSA
$3.37B
$7.72M 0.16%
+187,199
QTTB icon
85
Q32 Bio
QTTB
$56.1M
$7.48M 0.15%
2,252,987
PMVP icon
86
PMV Pharmaceuticals
PMVP
$90.5M
$6.22M 0.13%
4,975,291
-1,000,000
KALV icon
87
KalVista Pharmaceuticals
KALV
$823M
$6.18M 0.13%
+382,400
PHVS icon
88
Pharvaris
PHVS
$1.84B
$5.7M 0.12%
+205,400
NSPR icon
89
InspireMD
NSPR
$75.4M
$5.58M 0.11%
3,133,405
+1,000,000
INSM icon
90
Insmed
INSM
$31.8B
$4.42M 0.09%
25,400
+11,941
PALI icon
91
Palisade Bio
PALI
$264M
$4.4M 0.09%
+1,871,420
BCAX
92
Bicara Therapeutics
BCAX
$919M
$3.52M 0.07%
+209,100
CGEM icon
93
Cullinan Oncology
CGEM
$916M
$2.79M 0.06%
270,006
-1,653,849
CCCC icon
94
C4 Therapeutics
CCCC
$262M
$2.68M 0.05%
1,404,902
-3,830,244
IMA
95
ImageneBio Inc
IMA
$75.1M
$2.61M 0.05%
378,556
ANRO icon
96
Alto Neuroscience
ANRO
$612M
$2.23M 0.05%
125,000
-125,000
RVMD icon
97
Revolution Medicines
RVMD
$19.7B
$2.06M 0.04%
+25,900
VTGN icon
98
VistaGen Therapeutics
VTGN
$23.2M
$2.03M 0.04%
3,060,000
OCUL icon
99
Ocular Therapeutix
OCUL
$1.95B
$1.91M 0.04%
+157,300
PTGX icon
100
Protagonist Therapeutics
PTGX
$5.76B
$1.9M 0.04%
+21,700